Literature DB >> 17573976

Understanding secondary databases: a commentary on "Sources of bias for health state characteristics in secondary databases".

Sebastian Schneeweiss1.   

Abstract

Mesh:

Year:  2007        PMID: 17573976      PMCID: PMC2905674          DOI: 10.1016/j.jclinepi.2006.10.019

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  11 in total

1.  Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

Authors:  S Schneeweiss; J D Seeger; M Maclure; P S Wang; J Avorn; R J Glynn
Journal:  Am J Epidemiol       Date:  2001-11-01       Impact factor: 4.897

2.  Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance.

Authors:  Sebastian Schneeweiss; Malcolm Maclure; Stephen B Soumerai; Alexander M Walker; Robert J Glynn
Journal:  J Clin Epidemiol       Date:  2002-08       Impact factor: 6.437

3.  Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies.

Authors:  Sebastian Schneeweiss; Philip S Wang
Journal:  J Clin Psychopharmacol       Date:  2004-12       Impact factor: 3.153

4.  Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration.

Authors:  Til Stürmer; Sebastian Schneeweiss; Jerry Avorn; Robert J Glynn
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

5.  Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.

Authors:  M Alan Brookhart; Philip S Wang; Daniel H Solomon; Sebastian Schneeweiss
Journal:  Epidemiology       Date:  2006-05       Impact factor: 4.822

6.  Controlling confounding when studying large pharmacoepidemiologic databases: a case study of the two-stage sampling design.

Authors:  J P Collet; D Schaubel; J Hanley; C Sharpe; J F Boivin
Journal:  Epidemiology       Date:  1998-05       Impact factor: 4.822

7.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

8.  A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors.

Authors:  Sebastian Schneeweiss; Robert J Glynn; Jerry Avorn; Daniel H Solomon
Journal:  J Clin Epidemiol       Date:  2005-01       Impact factor: 6.437

9.  Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs.

Authors:  Giovanni Corrao; Antonella Zambon; Silvia Faini; Vincenzo Bagnardi; Olivia Leoni; Samy Suissa
Journal:  J Clin Epidemiol       Date:  2005-01       Impact factor: 6.437

10.  Validation of diagnostic codes within medical services claims.

Authors:  Machelle Wilchesky; Robyn M Tamblyn; Allen Huang
Journal:  J Clin Epidemiol       Date:  2004-02       Impact factor: 6.437

View more
  11 in total

Review 1.  Developments in post-marketing comparative effectiveness research.

Authors:  S Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2007-06-06       Impact factor: 6.875

2.  First trimester exposure to antiretroviral therapy and risk of birth defects.

Authors:  Kelesitse Phiri; Sonia Hernandez-Diaz; Kate B Dugan; Paige L Williams; Judith A Dudley; Astride Jules; S Todd Callahan; George R Seage; William O Cooper
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

3.  High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.

Authors:  Sebastian Schneeweiss; Jeremy A Rassen; Robert J Glynn; Jerry Avorn; Helen Mogun; M Alan Brookhart
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

4.  Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries.

Authors:  Preciosa M Coloma; Vera E Valkhoff; Giampiero Mazzaglia; Malene Schou Nielsson; Lars Pedersen; Mariam Molokhia; Mees Mosseveld; Paolo Morabito; Martijn J Schuemie; Johan van der Lei; Miriam Sturkenboom; Gianluca Trifirò
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

5.  Positive predictive value of the ICD-10 hospital diagnosis of pleural empyema in the Danish National Registry of Patients.

Authors:  Mette Søgaard; Jette Brommann Kornum; Henrik Carl Schønheyder; Reimar Wernich Thomsen
Journal:  Clin Epidemiol       Date:  2011-02-23       Impact factor: 4.790

6.  Primary versus secondary source of data in observational studies and heterogeneity in meta-analyses of drug effects: a survey of major medical journals.

Authors:  Guillermo Prada-Ramallal; Fatima Roque; Maria Teresa Herdeiro; Bahi Takkouche; Adolfo Figueiras
Journal:  BMC Med Res Methodol       Date:  2018-09-27       Impact factor: 4.615

7.  Impact of Age and Sex on Outcomes and Hospital Cost of Acute Asthma in the United States, 2011-2012.

Authors:  Joe G Zein; Belinda L Udeh; W Gerald Teague; Siran M Koroukian; Nicholas K Schlitz; Eugene R Bleecker; William B Busse; William J Calhoun; Mario Castro; Suzy A Comhair; Anne M Fitzpatrick; Elliot Israel; Sally E Wenzel; Fernando Holguin; Benjamin M Gaston; Serpil C Erzurum
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

8.  A General Framework for Considering Selection Bias in EHR-Based Studies: What Data Are Observed and Why?

Authors:  Sebastien Haneuse; Michael Daniels
Journal:  EGEMS (Wash DC)       Date:  2016-08-31

9.  Effect of glycemic control on the risk of pancreatic cancer: A nationwide cohort study.

Authors:  Kian-Ching Er; Chen-Yang Hsu; Yi-Kung Lee; Ming-Yuan Huang; Yung-Cheng Su
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 10.  Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects.

Authors:  Sebastian Schneeweiss
Journal:  Clin Epidemiol       Date:  2018-07-06       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.